Andrology Research Unit, Developmental and Regenerative Biomedicine Research Group, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom.
N Engl J Med. 2010 Jul 8;363(2):123-35. doi: 10.1056/NEJMoa0911101. Epub 2010 Jun 16.
The association between aging-related testosterone deficiency and late-onset hypogonadism in men remains a controversial concept. We sought evidence-based criteria for identifying late-onset hypogonadism in the general population on the basis of an association between symptoms and a low testosterone level.
We surveyed a random population sample of 3369 men between the ages of 40 and 79 years at eight European centers. Using questionnaires, we collected data with regard to the subjects' general, sexual, physical, and psychological health. Levels of total testosterone were measured in morning blood samples by mass spectrometry, and free testosterone levels were calculated with the use of Vermeulen's formula. Data were randomly split into separate training and validation sets for confirmatory analyses.
In the training set, symptoms of poor morning erection, low sexual desire, erectile dysfunction, inability to perform vigorous activity, depression, and fatigue were significantly related to the testosterone level. Increased probabilities of the three sexual symptoms and limited physical vigor were discernible with decreased testosterone levels (ranges, 8.0 to 13.0 nmol per liter [2.3 to 3.7 ng per milliliter] for total testosterone and 160 to 280 pmol per liter [46 to 81 pg per milliliter] for free testosterone). However, only the three sexual symptoms had a syndromic association with decreased testosterone levels. An inverse relationship between an increasing number of sexual symptoms and a decreasing testosterone level was observed. These relationships were independently confirmed in the validation set, in which the strengths of the association between symptoms and low testosterone levels determined the minimum criteria necessary to identify late-onset hypogonadism.
Late-onset hypogonadism can be defined by the presence of at least three sexual symptoms associated with a total testosterone level of less than 11 nmol per liter (3.2 ng per milliliter) and a free testosterone level of less than 220 pmol per liter (64 pg per milliliter).
与衰老相关的睾丸激素缺乏与男性迟发性性腺功能减退症之间的关联仍然是一个有争议的概念。我们根据症状与低睾丸激素水平之间的关联,寻求基于证据的标准来确定一般人群中的迟发性性腺功能减退症。
我们在八个欧洲中心对 3369 名年龄在 40 至 79 岁之间的随机人群样本进行了调查。使用问卷,我们收集了有关受试者一般、性、身体和心理健康的数据。使用质谱法测量清晨血液样本中的总睾酮水平,并使用 Vermeulen 公式计算游离睾酮水平。数据被随机分为单独的训练集和验证集,用于确认性分析。
在训练集中,早晨勃起不良、性欲低下、勃起功能障碍、无法进行剧烈活动、抑郁和疲劳等症状与睾丸激素水平显著相关。随着睾丸激素水平的降低,可以识别出三种性症状和有限的体力活力的可能性增加(范围,总睾酮为 8.0 至 13.0 nmol/L[2.3 至 3.7ng/ml],游离睾酮为 160 至 280 pmol/L[46 至 81pg/ml])。然而,只有三种性症状与睾丸激素水平降低具有综合征相关性。随着性症状数量的增加,与睾丸激素水平降低呈反比关系。这些关系在验证集中得到了独立证实,其中症状与低睾丸激素水平之间的关联强度确定了识别迟发性性腺功能减退症所需的最低标准。
迟发性性腺功能减退症可以定义为至少有三种与总睾酮水平低于 11 nmol/L(3.2ng/ml)和游离睾酮水平低于 220 pmol/L(64pg/ml)相关的性症状。